Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol
- PMID: 23625787
- DOI: 10.1002/phar.1280
Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol
Abstract
Study objective: To identify specific risk factors for excessive anticoagulation, defined as an international normalized ratio (INR) higher than 5, in hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol.
Design: Retrospective nested case-control study.
Setting: Large academic tertiary care medical center.
Patients: Hospitalized nonsurgical patients 18 years or older who received at least one dose of warfarin according to the pharmacist-managed protocol from January 1, 2009, to January 31, 2012, were included. Patients who experienced an INR higher than 5 were designated as case patients; those who received warfarin for at least as many days as the case patients but who did not experience an INR more than 5 were deemed control patients. Controls were matched to cases in a 2:1 ratio by age, sex, INR goal, and type of warfarin therapy (new start or continuation).
Measurements and main results: A total of 87 case patients were matched to 174 controls. Ten different hypothesized risk factors were examined. Two variables, severity of illness score (odds ratio [OR] 4.89, p<0.001) and poor nutritional status (OR 4.27, p<0.001), demonstrated strong independent associations with risk of excessive anticoagulation. Administration of interacting drugs that highly potentiate warfarin's effect (OR 2.26, p=0.011) and concurrent diarrheal illness (OR 4.75, p<0.001) also displayed a statistically significant risk for excessive anticoagulation.
Conclusion: Even in a highly standardized system for warfarin dosing by a pharmacist-managed protocol, higher disease severity and poor nutritional status placed hospitalized patients at greater risk of experiencing excessive anticoagulation. In addition, administration of interacting drugs that highly potentiate warfarin's effect or the occurrence of diarrheal illness may predict increased risk.
Keywords: INR; excessive anticoagulation; hospitalization; international normalized ratio; warfarin.
© 2013 Pharmacotherapy Publications, Inc.
Similar articles
-
Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12. J Clin Pharm Ther. 2011. PMID: 21070296
-
Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.Pharmacotherapy. 2011 Jul;31(7):686-94. doi: 10.1592/phco.31.7.686. Pharmacotherapy. 2011. PMID: 21923456
-
Comparison of two different models of anticoagulation management services with usual medical care.Pharmacotherapy. 2010 Apr;30(4):330-8. doi: 10.1592/phco.30.4.330. Pharmacotherapy. 2010. PMID: 20334453
-
Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance.J Thromb Thrombolysis. 2006 Aug;22(1):23-30. doi: 10.1007/s11239-006-8328-9. J Thromb Thrombolysis. 2006. PMID: 16786229 Review.
-
Oral vitamin K1: an option to reduce warfarin's activity.Ann Pharmacother. 1995 Dec;29(12):1228-32. doi: 10.1177/106002809502901207. Ann Pharmacother. 1995. PMID: 8672826 Review.
Cited by
-
A prospective study investigating the causes of warfarin under-utilization in Chinese patients.Int J Clin Pharm. 2016 Oct;38(5):1286-93. doi: 10.1007/s11096-016-0367-5. Epub 2016 Aug 3. Int J Clin Pharm. 2016. PMID: 27488309
-
Correlation between Rs2108622 Locus of CYP4F2 Gene Single Nucleotide Polymorphism and Warfarin Dosage in Iranian Cardiovascular Patients.Iran J Pharm Res. 2017 Summer;16(3):1238-1246. Iran J Pharm Res. 2017. PMID: 29201113 Free PMC article.
-
Enhancing postoperative anticoagulation therapy with remote patient monitoring: A pilot crossover trial study to evaluate portable coagulometers and chatbots in cardiac surgery follow-up.Digit Health. 2024 Aug 6;10:20552076241269515. doi: 10.1177/20552076241269515. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 39139188 Free PMC article.
-
Improving inpatient warfarin therapy safety using a pharmacist-managed protocol.BMJ Open Qual. 2018 Apr 20;7(2):e000290. doi: 10.1136/bmjoq-2017-000290. eCollection 2018. BMJ Open Qual. 2018. PMID: 29713691 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical